Tirellizumab Combined With Chemotherapy Monotherapy for Non-small Cell Lung Cancer
Clinical trial NCT05965102 · UNKNOWN
Trial details
- NCT number
- NCT05965102
- Sponsor
- Second Affiliated Hospital of Guangzhou Medical University
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-01
- Primary completion
- 2025-04-01
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.